EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Schisandra chinensis mixture attenuates diabetic kidney disease via VDAC1/Grp75/IP3R-mediated MAMs stabilization and apoptosis-autophagy regulation

Hongdian Li, Ao Dong, Cong Liu, Pengfei He, Yu Ma, Shu Chen, Shaoning Dong, Sai Zhang, Minying Zhang, Mianzhi Zhang

Phytomedicine · 2025

DOI: 10.1016/j.phymed.2025.157164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Hongdian Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: tianjin hospital of ITCWM nankai hospital, Tianjin Medical University, Tianjin, China; Yuquan Hospital, School of Clinical Medicine, Tsinghua Univers…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Schisandra. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tianjin Medical University, Beijing Natural Science Foundation, Tianjin Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Diabetic kidney disease (DKD) is a major cause of end-stage renal disease, with mitochondrial dysfunction-mediated tubular injury implicated in its pathogenesis. Mitochondria-associated membranes (MAMs) coordinate apoptosis and autophagy in diabetic tubular injury. While Schisandra chinensis Mixture (SM) shows renoprotective effects, its mechanism in counteracting hyperglycemia-induced tubular cell death and fibrosis via MAMs integrity remains unclear. OBJECTIVE: This study investigated whether SM alleviates renal fibrosis by restoring MAMs integrity under high glucose (HG) conditions, thereby regulating renal tubular cell apoptosis and autophagy. METHODS: DKD was induced in Sprague-Dawley rats through high-fat/high-glucose diet and streptozotocin injection, followed by 12-week treatment with SM (1.5/3/6 g/kg/d). Renal function, injury markers and histopathology were assessed. Apoptosis, autophagy, and fibrosis were characterized by immunohistochemical localization, western blotting quantification, and TUNEL assay. Mitochondria-endoplasmic reticulum (ER) interactions and MAMs integrity were evaluated through ultrastructural and molecular analyses. In vitro, the protective mechanism of SM was validated through lentiviral-mediated manipulation of MAMs integrity. Serum components of SM were characterized by ultra-performance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS). RESULTS: In DKD rats, SM treatment restored mitochondrial-ER ultrastructure and coupling, evidenced by enhanced interactions of MAMs tethering proteins. SM dose-dependently improved renal function, attenuated tubular apoptosis, restored HG-impaired autophagy, and mitigated fibrosis. In HG-stimulated HK-2 cells, SM similarly rescued mitochondrial-ER proximity and suppressed fibrotic markers. Lentiviral models further confirmed that SM alleviates tubular injury by preserving MAMs integrity. UPLC-MS/MS identified major serum constituents of SM (e.g., schisandrin C); their individual bioactivities were not assessed in this study. CONCLUSION: SM treats DKD by MAMs integrity through the VDAC1-Grp75-IP3R axis, regulating HG-stimulated apoptosis and autophagy in renal tubular cells, improving mitochondrial function, and suppressing fibrotic progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesSchisandraAnimalsRats, Sprague-DawleyApoptosisAutophagyMaleRatsMitochondriaVoltage-Dependent Anion Channel 1Diabetes Mellitus, Experimental

Stichwörter der Autor:innen

ApoptosisAutophagyDiabetic kidney diseaseMitochondria-associated membranesSchisandra chinensis Mixture

Substanzen

Voltage-Dependent Anion Channel 1Vdac1 protein, rat

Autor:innen und Institutionen

  • tianjin hospital of ITCWM nankai hospital, Tianjin Medical University, Tianjin, China; Yuquan Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China; Dongfang Hospital, Beijing University of Chinese…
  • Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China; Fengtai District Hospital Management Center, Beijing, China.
  • Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
  • Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
  • School of Medicine, Nankai University, Tianjin, China. Electronic address: zhangminying@nankai.edu.cn.
  • tianjin hospital of ITCWM nankai hospital, Tianjin Medical University, Tianjin, China; Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China; Dongfang Hospital, Beijing University of Chines…

Förderung

  • Tianjin Medical University
  • Beijing Natural Science Foundation
  • Tianjin Municipal Science and Technology Bureau
  • Tianjin Municipal Science and Technology Program

Zitieren

APA

Li, H., Dong, A., Liu, C., He, P., Ma, Y., Chen, S., Dong, S., Zhang, S., Zhang, M., & Zhang, M. (2025). Schisandra chinensis mixture attenuates diabetic kidney disease via VDAC1/Grp75/IP3R-mediated MAMs stabilization and apoptosis-autophagy regulation. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157164

Vancouver

Li H, Dong A, Liu C, He P, Ma Y, Chen S, et al. Schisandra chinensis mixture attenuates diabetic kidney disease via VDAC1/Grp75/IP3R-mediated MAMs stabilization and apoptosis-autophagy regulation. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157164

BibTeX
@article{Li2025,
  author = {Li, Hongdian and Dong, Ao and Liu, Cong and He, Pengfei and Ma, Yu and Chen, Shu and Dong, Shaoning and Zhang, Sai and Zhang, Minying and Zhang, Mianzhi},
  title = {Schisandra chinensis mixture attenuates diabetic kidney disease via VDAC1/Grp75/IP3R-mediated MAMs stabilization and apoptosis-autophagy regulation},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2025.157164}
}
Kostenlos starten →